Early BPD Screening Benefits for Black Youth: Expert Opinion

Sickle cell disease is a genetic blood disorder that affects the structure and function of red blood cells. In people with this condition, red blood cells become rigid and shaped like crescents or sickles instead of being round and flexible. These abnormally shaped cells can block blood flow through small blood vessels, leading to pain, organ damage, and various complications. The disease is inherited when a child receives two copies of the sickle cell gene, one from each parent. Laboratory testing plays a crucial role in diagnosing sickle cell disease and monitoring the health of affected individuals.

Several laboratory tests are used to detect and confirm sickle cell disease. The most common screening test is hemoglobin electrophoresis, which separates different types of hemoglobin in the blood and can identify abnormal hemoglobin S, the hallmark of sickle cell disease. A complete blood count may show anemia with characteristic changes in red blood cell shape and size. Newborn screening programs routinely test for sickle cell disease using blood spot samples, allowing for early detection and intervention. Additional tests such as a sickle cell solubility test or high-performance liquid chromatography may be performed to confirm the diagnosis.

For individuals already diagnosed with sickle cell disease, regular laboratory monitoring is essential to manage the condition and prevent complications. Periodic complete blood counts help track anemia severity and detect changes that might signal complications. Reticulocyte counts measure how quickly the body is producing new red blood cells to replace those destroyed by sickling. Blood chemistry panels monitor kidney and liver function, as these organs can be damaged by repeated episodes of blocked blood flow. Tests measuring bilirubin levels help assess the breakdown of red blood cells, while iron studies ensure that iron levels remain balanced.

Genetic testing and counseling are important for families affected by sickle cell disease. Carrier testing can identify individuals who have one copy of the sickle cell gene and could pass it to their children, even though they typically do not show symptoms themselves. Prenatal testing options are available for couples at risk of having a child with sickle cell disease. These tests provide valuable information for family planning and allow parents to prepare for appropriate medical care if needed. Understanding test results and their implications is best done in consultation with healthcare providers who specialize in genetic blood disorders.